Member Info for PDMSPiper

ODX own the CE approved tech utilised on that stick. Its their existing CD4 HIV test stick.

No. Wrong. Mologic not in the Consortium.

Graphite.....This new antibody test is based on Omegas existing CD4 HIV Test stick and is simply being modified to accept a test strip for Covid. That tech has already been CE approved and is ready to go.
Are some idiots intimating that Omega will earn nothing from that as these tests are rolled out around the globe and probably made under license in other countries. Massive potential.

All eyes on the Andrew Marr show coming up now on BBC1. The preview said they will be discussing the exit strategy. They always do a newspaper review as well so no doubt there will be a discussion about Antibody testing given todays excviting developments.
Eyes on!!
Now!!

The media exposure will be massive because of that front page. Tune into the Marr show today for the newspaper review. Every punter will be googling who is in the consortium then they’ll discover that ODX is the only one they can buy stock in. This is very much still under the radar as far as the wider investing community goes. All that will change this week. I’d expect pieces on ODX in the FT, Telegraph and financial sections of all the quality press.

Additionally, we should be rapidly into production as these antibody tests are based on Omegas existing test for HIV which is the CD4 Test platform. The test is already CE marked and approved.
The CD4 Test has just been modified to take the Covid19 test strip but the test hardware itself is already approved and CE marked and wholly owned by Omega.
Rapid production ramp and licensed global production with royalties to Omega for the CD4 tech. Happy days.

And a chunk of that £10 will be going to ODX as we own the existing CD4 tech platform that this test is based on.
As far as I understand it, that white plastic stick in the photo on the front of the mail is Omegas CD4 Test as Dibs described earlier. Royalties on global production coming.

Just been laughing into my cornflakes watching BBC breakfast as the red haired presenter girl held up the front page of the mail and talked about the antibody tests being a game changer and thinking about the ********s who’ve been deramping it for weeks like Ponkey ha ha noobs! Lol

You Salty Sellers should have listened to Uncle Piper.
Uncle piper told you this was 7 days and there was a high chance of developments over the weekend.
Should have listened to Uncle Piper. LOL.

The newspaper reviewers are too thick to recognize the significance of the story Tony.

Very interesting Dibs.

If the base tech of this is Onegas own CE marked CE4 Test then I would think as well as the obvious manufacturers margins Omega will be lined up for royalty payments throughout the world.
What if Roche or GSK come onboard with the consortium to ramp up production? Omega could be earning a quid each for Billions of these sold throughout the world based on our ownership of the CD4 tech.
I like it.

80% gap up on on open. My guess on a good RNS with order numbers and timescales is an 80% gap up in the morning auction to about 70p.
Without the sellers we would have been well into the 50’s now on volume anyway.
Money flooding in here for the 5 bagger. £250Mill Mcap coming.

Boom!!! Unlucky if you sold out fellas but there’s an RNS dropping Monday....

https://mol.im/a/8257233

“The new immunity tests, expected to cost £10, have been devised by scientists at Oxford, working for the Government-backed Rapid Testing Consortium.
Users of the test provide a pinprick of blood for analysis. Then, like a pregnancy test, if two lines appear after a 20-minute wait, people know that they have the antibodies. One line means they are either vulnerable to coronavirus infection or the test has failed.
Under plans being drawn up, the user would take a picture of the positive result and send it to a central unit which would enter their details into a database.”

Yes, Richard Sneller, his wife, his accountant and HMRC. Nobody else needs to know.

If AVCTs primary business is oncology then they weren’t doing much of it. Their last reported revenue was only £4Million. That only supports an Mcap of £20Mill Max. AVCT Mcap is now £160Mill. The 8X bagger rise has happened because of Covid speculation. The affirmer technology is not proven to work on Cytivas test strip yet. That’s why I’m not buying it.
1.) The Mcap is massively toppy and based on speculative hot money.
2.) The Covid partnership that caused the astronomical rise is not yet proven to work.
I think it’s a very high risk play here but good luck with it and DYOR.

It isn’t advice. It’s just my opinion. Don’t take advice from anybody else.

It’s his private holding. He gifted 5% to charity. As a fund, Bailie Gifford can’t give their clients money away to charity.

Not my strategy mate. I don’t buy toppy MCaps with very little justification by revenue. IMO there will be a massive sell off in both AVCT and NCYT soon. There’s too much hot speculative money in there just waiting for the last bits of news before they dump them. Massive Mcaps, 163Mill and 288Mill.
Some loons are saying AVCT is going to 10bag on news. Ha. That will be a £1.63Bill Mcap. They’ll be lucky to get another bag out of it but the affirmer tech has even been proven to work on Cytivas strip yet so it could even go back to pennies. It’s a poor risk reward. I don’t risk losing all my capital in pursuit of a possible bagger. Not for me. I’ll play the long game and wait for ODX to steadily reach a £250 mill Mcap on news and revenue. Much safer. Much more sustainable. The stocks in my isa as a long term hold. Sell offs and retraces coming in the others. All too toppy.

Another bedwetter insecure in his own position who feels the need to come over here. Lol
Big sell off and retrace coming in these other Covids with overbought toppy Mcaps. Only ODX is in a scheme with guaranteed government orders. The rest of you are full of speculative hot money. ODX by far the lowest Mcap at £50Mill and by far the most attractive risk v reward profile.

Nobody can answer the question because the data isn’t available yet. That’s why they are instigating a mass antibody testing program to obtain the data, answer your question and use the data to develop a safe vaccine.